# A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)

> **NCT06114056** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **West China Hospital** · enrollment: 3 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **BIOLOGICAL:** JWK007 Single intravenous infusion administration

## Key facts

- **NCT ID:** NCT06114056
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2029-11-13
- **Final completion:** 2029-11-13
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114056, "A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06114056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*